Stereotactic radiosurgery and combined immune checkpoint therapy with ipilimumab and nivolumab in patients with melanoma brain metastases: A retrospective monocentric toxicity analysis.
Clin Transl Radiat Oncol
; 39: 100573, 2023 Mar.
Article
en En
| MEDLINE
| ID: mdl-36655118
AE, Adverse events; CTCAE, Common Terminology Criteria for Adverse Events; Checkpoint inhibition; GPA, graded prognostic assessment; IPI, ipilimumab; Intracranial hemorrhage; Ipilimumab; LDH, lactate dehydrogenase; MBM, Melanoma brain metastases; MRI, magnet resonance imaging; NIVO, nivolumab; Nivolumab; OS, overall survival; PFS, progression-free survival; RN, radiation necrosis; Radiation necrosis; SRS, Stereotactic radiosurgery; SRT, Stereotactic radiotherapy; Side effects; Stereotactic radiosurgery
Texto completo:
1
Banco de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Año:
2023
Tipo del documento:
Article